BP538

カプトプリル

British Pharmacopoeia (BP) Reference Standard

• 別名: N-[(S)-3-メルカプト-2-メチルプロピオニル]-L-プロリン
• 実験式（ヒル表記法）: C₉H₁₅NO₃S
• CAS番号: 62571-86-2
• 分子量: 217.29
• Beilstein: 477887
• MDL番号: MFCD00168073
• UNSPSCコード: 41116107
• NACRES: NA.24

特性

• グレード: pharmaceutical primary standard
• APIファミリー: captopril
• フォーム: crystalline
• シェルフライフ: limited shelf life, expiry date on the label
• メーカー／製品名: BP
• mp: 104-108 °C (lit.)
• アプリケーション: pharmaceutical; pharmaceutical small molecule
• フォーマット: neat
• 保管温度: 2-8°C
• SMILES記法: C[C@H](CS)C(=O)N1CCC[C@H]1C(O)=O
• InChI: 1S/C9H15NO3S/c1-6(5-14)8(11)10-4-2-3-7(10)9(12)13/h6-7,14H,2-5H2,1H3,(H,12,13)/t6-,7+/m1/s1
• InChI Key: FAKRSMQSSFJEIM-RQJHMYQMSA-N
• 遺伝子情報: human ... ACE(1636)

詳細

詳細

This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the issuing Pharmacopoeia. For further information and support please go to the website of the issuing Pharmacopoeia.

アプリケーション

Captopril BP Reference standard, intended for use in laboratory tests only as specifically prescribed in the British Pharmacopoeia.

Also used in monographs such as:

Captopril Tablets

Captopril Oral Solution

生物化学的／生理学的作用

アンジオテンシン変換酵素阻害剤です。アンジオテンシンⅡの形成を阻害します。血管形成を促進し、微小血管密度を増加させる生理活性ペプチドです。

包装

Unit quantity: 100 mg. Subject to change. The product is delivered as supplied by the issuing Pharmacopoeia. For the current unit quantity please visit British Pharmacopoeia

その他情報

Sales restrictions may apply.

安全性情報

• ピクトグラム: GHS08
• シグナルワード: Danger
• 危険有害性情報: H341,H360F
• 注意書き: P201 - P202 - P280 - P308 + P313 - P405 - P501
• 危険有害性の分類: Muta. 2 - Repr. 1B
• 保管分類コード: 6.1C - Combustible acute toxic Cat.3 / toxic compounds or compounds which causing chronic effects
• WGK: WGK 2
• 引火点(°F): Not applicable
• 引火点(℃): Not applicable